pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,973 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 17 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,346
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07388459: Natural History, Evolution, and Clinical Features of Autoimmune Atrophic Gastritis

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Atrophic Gastritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05571579: Biological Collection of Brain Tumors

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Brain Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04267796: Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Breast Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05263362: An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)

    Sponsor: Erasmus Medical Center. Phase: . Conditions: Breast Fibrosis, Breast Cancer, Breast Cancer Female, Breast Neoplasms, Breast Carcinoma in Situ, Breast Carcinoma

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05401227: Glutamatergic Mechanisms: Aim2

    Sponsor: New York State Psychiatric Institute. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07477327: Is 6 Weeks Immobilization for a Chopart Injury Still State of the Art? Comparison Between Cast Immobilization Versus Functional Treatment

    Sponsor: Hôpital Fribourgeois. Phase: NA. Conditions: Foot Ankle Injuries

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07113561: Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance

    Sponsor: Norwegian University of Science and Technology. Phase: NA. Conditions: Obesity (Body Mass Index >30 kg/m2)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05147142: Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety

    Sponsor: Ocean State Research Institute, Inc.. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07561970: COmparison of Maintenance of Propofol And Sevoflurane Spectral Study

    Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Electroencephalography/Drug Effects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07323173: A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

    Sponsor: Nanjing Leads Biolabs Co.,Ltd. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568041: Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

    Sponsor: Cenna Biosciences Inc.. Phase: PHASE1. Conditions: Alzheimer's Disease (AD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07404254: Effects of Variations in Caffeinated Beverages on Well-being

    Sponsor: GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.. Phase: NA. Conditions: Healthy, Caffeine, Beverage Intake

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06231654: Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics

    Sponsor: Fondation Lenval. Phase: NA. Conditions: Using Remote Photoplethysmography for Physiological Parameters

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05377554: Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

    Sponsor: Alume Biosciences, Inc.. Phase: PHASE3. Conditions: Surgery

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07474805: Outcomes of Renal Replacement in Mexico

    Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran. Phase: . Conditions: Chronic Kidney Disease - Stage V, Chronic Kidney Disease on Hemodialysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07464366: The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study

    Sponsor: Ji Dongmei. Phase: PHASE2. Conditions: Salivary Gland Carcinomas

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01952366: Prognosis of Depression in the Elderly (PRODE). A Multicentre, Longitudinal Study of Elderly Depressed Patients.

    Sponsor: Sykehuset Innlandet HF. Phase: . Conditions: Depression, Dementia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07175922: Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

    Sponsor: Vertero Therapeutics. Phase: . Conditions: Parkinsons Disease (PD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07510594: A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC

    Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Large-Cell Neuroendocrine Carcinoma of the Lung, Extrapulmonary Neuroendocrine Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06506266: Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06741618: MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

    Sponsor: Columbia University. Phase: NA. Conditions: HIV/AIDS

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07527091: Efficacy of Ultrasound-Guided Percutaneous Electrolysis for Hip Pain in Male Ice Hockey Players

    Sponsor: Veronique Vidal. Phase: NA. Conditions: Groin Pain, Hip Joint Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07139210: EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVE DISORDER

    Sponsor: Cairo University. Phase: NA. Conditions: Cognitive Function, Quality of Life, ADHD - Attention Deficit Disorder With Hyperactivity, Motor Abilities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07419113: Development of an Integrated Multi-channel Artificial Nose for Cancer Detection (UNos)

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07473713: Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia

    Sponsor: Tufts Medical Center. Phase: PHASE1. Conditions: Osteopenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06120660: Musical Intervention and Physiological Stress and Inflammatory Biomarkers in Mechanically Ventilated ICU Patients

    Sponsor: University of Oviedo. Phase: NA. Conditions: Sedation, Critical Illness, Respiration, Artificial, Inflammation, Stress, Physiological

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06100913: Immunology of Ebola Vaccine

    Sponsor: Emory University. Phase: PHASE2. Conditions: Ebola Virus Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06069713: Consumer Perceptions of Cannabidiol (CBD) Health Claims

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Perceptions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07336160: ERAS-Based Preoperative Nutrition and Fasting in Total Knee Arthroplasty

    Sponsor: Nermin Ocaktan. Phase: NA. Conditions: Total Knee Arthroplasty, Postoperative Nausea and Vomiting

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07249879: This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE1. Conditions: Relapsed/Refractory Small Cell Lung Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02354079: HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Hypobetalipoproteinemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05397496: Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06217588: LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study

    Sponsor: University of Pennsylvania. Phase: . Conditions: LCAT Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07379788: ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

    Sponsor: Rehab Werida. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07550803: Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Sleep Disturbance

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05200442: A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

    Sponsor: University of Chicago. Phase: PHASE1. Conditions: Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic, Advanced Colorectal Carcinoma, Advanced Colorectal Adenocarcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07427186: Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

    Sponsor: Institut Claudius Regaud. Phase: NA. Conditions: Solid Cancers

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07406386: Integrating Halotherapy Into Preseason Training Improves Respiratory and Aerobic Performance in Elite Female Soccer Players

    Sponsor: Gümüşhane Universıty. Phase: NA. Conditions: Aerobic Performance, Respiratory Function, Athletic Performance, Respiratory Muscle Strength, Elite Female Athletes, Halotherapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07366086: Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

    Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07334886: A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07571070: High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur Boxers

    Sponsor: Federal University of Vicosa. Phase: NA. Conditions: Athletic Performance, Exercise Training, Physical Fitness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07457970: Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy

    Sponsor: University of South Carolina. Phase: NA. Conditions: Blood Pressure Monitoring, Hypertension (HTN), Pregnancy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07541469: Rezdiffra Pregnancy and Lactation Registry

    Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: . Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07381283: Immediate Versus Delayed Loading of Dental Implants in the Anterior Maxilla

    Sponsor: Suez Canal University. Phase: NA. Conditions: Partial Edentulism of the Maxilla, Dental Implant Loading, Tooth Loss in the Anterior Maxilla

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05335941: A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma, Metastatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06893341: Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

    Sponsor: Indiana University. Phase: NA. Conditions: Diabetes, Hyperglycemia, Hypoglycemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07521241: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

    Sponsor: Addpharma Inc.. Phase: PHASE1. Conditions: Chronic Liver Disease (CLD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01143454: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Metabolic Disease, Obesity, Li-Fraumeni Syndrome, Cardiomyopathy, Atherosclerosis, Inflammatory Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06243354: Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation

    Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd. Phase: PHASE1. Conditions: Safety, Tolerability, Efficacy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05408494: Engaging Men in Weight Loss With a Game-based mHealth and Neurotraining Program

    Sponsor: Drexel University. Phase: NA. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ← prev
    page 25 of 100
    next →